PRP intraovarian injection improves the number and quality of blastocysts in mouse models

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 17 on September 13, 2024, entitled, “Intraovarian PRP injection improves oocyte quality and early embryo development in mouse models of chemotherapy-induced diminished ovarian reserve.”

J&J budgets over $2B for new North Carolina biologics facility

Johnson & Johnson is earmarking over $2 billion to build a new biologics manufacturing facility in Wilson, NC, for a variety of therapies for oncology

October 3, 2024

Intellia’s gene editing therapy shows early potential in rare heart condition – Pharmaceutical Technology

Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) presents with symptoms primarily related to heart failure and impaired cardiac function. Credit: Rawpixel.com via Shutterstock. Intellia Therapeutics has announced

November 18, 2024

Biocytogen and Ona enter cancer ADC development deal

Share this article The agreement will facilitate the development of antibody-drug conjugates for solid tumours. Credit: Spectral-Design / Shutterstock.com. Biocytogen Pharmaceuticals and Spanish biotech company

December 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.